Shares of Centrus Energy Corp. rallied 7.6% to $203.35 on June 2, extending a powerful multi-session climb as investors continued digesting the nuclear fuel supplier's Q1 2026 report and its decision to raise full-year revenue guidance. The question now: whether Washington's bet on domestic uranium enrichment can translate into profits fast enough to support a stock trading at roughly 60 times earnings.

  • The Earnings Beat That Sparked the Rally

Centrus posted Q1 adjusted earnings per share of $1.05, crushing the Wall Street consensus of $0.32 by more than 228%.

Revenue came in at $76.7 million, up from $73.1 million a year earlier, driven by a surge in its government-linked Technical Solutions business to $32.1 million from $21.8 million.

Net income, however, fell to $10 million from $27.2 million, weighed down by higher expansion costs. The adjusted beat gave bulls the ammunition; the headline decline gave skeptics pause.

  • A Higher Revenue Target Backed by a Massive Backlog

Centrus raised its 2026 revenue guidance to $450–$500 million, up from $425–$475 million.

The company sits on a $3.9 billion backlog stretching to 2040, including roughly $3.1 billion in uranium fuel contracts. That backlog gives long-term revenue visibility rare in the energy sector, but investors are paying up for it — the stock's P/E ratio hovers around 60x , pricing in years of growth that hasn't materialized yet.

  • Government Money Is the Real Catalyst

Centrus is advancing a $560 million expansion of its Oak Ridge, Tennessee centrifuge plant with partners including Fluor and Palantir.

The firm is also eyeing a potential Department of Energy contract for advanced nuclear fuel production that could reach or exceed $1 billion. These federal dollars underwrite the growth story, but Centrus must scale capacity, manage construction, and meet regulatory requirements without costly delays or overruns — execution risk that rises with every dollar committed.

  • Falling Margins Are the Fine Print

Profit margins have compressed sharply: net margin dropped to roughly 13% from 23% a year ago , as spending on the manufacturing buildout eats into earnings. Centrus plans $350–$500 million in capital deployment this year alone. For shareholders, the trade-off is clear: accept thinner profits now for the promise of a domestic nuclear fuel monopoly later. Whether that promise is worth 60 times earnings remains the central debate.